Millennium Management
OLMA icon

Millennium Management’s Olema Pharmaceuticals OLMA Stock Holding History

Millennium Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.73M Sell
182,935
-315,555
-63% -$7.02M ﹤0.01% 3569
2025
Q4 		$12.5M Buy
498,490
+167,036
+50% +$2.97M 0.01% 2026
2025
Q3 		$3.24M Sell
331,454
-939,636
-74% -$5.64M ﹤0.01% 3572
2025
Q2 		$5.41M Buy
1,271,090
+292,242
+30% +$1.3M ﹤0.01% 2903
2025
Q1 		$3.68M Sell
978,848
-371
-0% -$1.87K ﹤0.01% 3170
2024
Q4 		$5.71M Buy
979,219
+901,159
+1,154% +$9M ﹤0.01% 2701
2024
Q3 		$932K Buy
+78,060
New +$998K ﹤0.01% 4337
2024
Q2 		– Sell
-88,257
Closed -$999K – 6345
2024
Q1 		$999K Buy
88,257
+1,005
+1% +$13K ﹤0.01% 4290
2023
Q4 		$1.22M Sell
87,252
-126,842
-59% -$1.7M ﹤0.01% 3997
2023
Q3 		$2.64M Sell
214,094
-53,463
-20% -$545K ﹤0.01% 3299
2023
Q2 		$2.42M Buy
267,557
+192,333
+256% +$1.16M ﹤0.01% 3306
2023
Q1 		$261K Sell
75,224
-660,729
-90% -$2.7M ﹤0.01% 5007
2022
Q4 		$1.8M Buy
735,953
+57,355
+8% +$167K ﹤0.01% 3651
2022
Q3 		$1.87M Buy
678,598
+35,254
+5% +$150K ﹤0.01% 3799
2022
Q2 		$2.62M Buy
643,344
+557,927
+653% +$1.77M ﹤0.01% 3426
2022
Q1 		$364K Sell
85,417
-162,911
-66% -$898K ﹤0.01% 5376
2021
Q4 		$2.32M Buy
+248,328
New +$5.15M ﹤0.01% 3637
2021
Q1 		– Sell
-18,553
Closed -$892K – 6357
2020
Q4 		$892K Buy
+18,553
New +$870K ﹤0.01% 3809

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Millennium Management's OLMA Position: Q1 2026 in Review

Millennium Management reduced its Olema Pharmaceuticals (OLMA) stake by 63% in Q1 2026, selling an estimated $7.02M and leaving 182,935 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Millennium Management first reported a position in OLMA in Q4 2020 and has held it in 18 quarters since. The position peaked at $12.5M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Millennium Management held 182,935 shares of Olema Pharmaceuticals worth $2.73M as of Q1 2026.
  • Millennium Management sold 315,555 Olema Pharmaceuticals shares in Q1 2026, an estimated $7.02M.
  • Olema Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3569 holding.
  • Millennium Management first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 18 quarters since.
  • Millennium Management's Olema Pharmaceuticals position peaked at $12.5M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.